ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 10530 recruiting trials
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
👨⚕️ Sahaja Acharya, MD, SKCCC Johns Hopkins Medical Institution📍 2 sites📅 Started Mar 2025View details ↗
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecruitingNCT07476365 ↗
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
RecruitingNCT06801756 ↗
Craniopharyngioma and Pregnancies
👨⚕️ Anne BACHELOT, MD, PhD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Mar 2025View details ↗
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
👨⚕️ Kaoutar JIDAR, MD, Medical Center of l'Institut Pasteur (CMIP)📍 1 site📅 Started Mar 2025View details ↗
Enrolling by InvitationNCT06880250 ↗
Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease
👨⚕️ Sergey V. Moiseev, MD, Sechenov First Moscow State Medical University (Sechenov University)📍 23 sites📅 Started Mar 2025View details ↗
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Abemaciclib in Newly Diagnosed Meningioma Patients
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
👨⚕️ Jacquelyn Crane, MD, Children's Hospital of Philadelphia📍 1 site📅 Started Mar 2025View details ↗
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
👨⚕️ Timothy Olson, MD, PhD, Children's Hospital of Philadelphia📍 1 site📅 Started Mar 2025View details ↗
Evaluation of Urinary Dysfunction in CANVAS Patients
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
👨⚕️ Jason D Roberts, MD MAS, McMaster University and Population Health Research Institute📍 17 sites📅 Started Mar 2025View details ↗
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
👨⚕️ Emmanuelle SAMALIN, MD, Institut du Cancer de Montepllier📍 21 sites📅 Started Mar 2025View details ↗
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
👨⚕️ Christian Buske, Prof. Dr., University Hospital Ulm Department of Internal Medicine III📍 11 sites📅 Started Mar 2025View details ↗
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →